More information about text formats
This is an interesting piece. Pharmaceutical companies have to publish payments made to individual, named physicians. (These are available at http://www.abpi.org.uk/ethics/ethical-responsibility/disclosure-uk/.) However, recipients can choose to remain unidentifiable (PMCPA Clause 24.9). In the figures for 2016, published in Disclosure UK in June 2017, 35% of health care professionals chose to remain incognito. In the GMC's Good Medical Practice they only recommend that physicians consider the PMCPA code. Perhaps they could be firmer in their recommendation.